Free Trial

Warby Parker (WRBY) Competitors

Warby Parker logo
$23.61 -0.34 (-1.42%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$23.52 -0.09 (-0.36%)
As of 08/1/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WRBY vs. PEN, STVN, GKOS, BLCO, SLNO, IRTC, INSP, TMDX, NVST, and PRCT

Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), Inspire Medical Systems (INSP), TransMedics Group (TMDX), Envista (NVST), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.

Warby Parker vs. Its Competitors

Penumbra (NYSE:PEN) and Warby Parker (NYSE:WRBY) are both mid-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

In the previous week, Penumbra had 37 more articles in the media than Warby Parker. MarketBeat recorded 50 mentions for Penumbra and 13 mentions for Warby Parker. Warby Parker's average media sentiment score of 1.18 beat Penumbra's score of 0.60 indicating that Warby Parker is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Penumbra
17 Very Positive mention(s)
6 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Warby Parker
8 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Penumbra has a net margin of 11.54% compared to Warby Parker's net margin of -1.79%. Penumbra's return on equity of 11.55% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Penumbra11.54% 11.55% 8.76%
Warby Parker -1.79%-2.48%-1.29%

Penumbra presently has a consensus target price of $300.47, suggesting a potential upside of 23.90%. Warby Parker has a consensus target price of $23.13, suggesting a potential downside of 2.05%. Given Penumbra's stronger consensus rating and higher possible upside, equities research analysts plainly believe Penumbra is more favorable than Warby Parker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Penumbra
0 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
2 Strong Buy rating(s)
2.94
Warby Parker
0 Sell rating(s)
9 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.53

88.9% of Penumbra shares are owned by institutional investors. Comparatively, 93.2% of Warby Parker shares are owned by institutional investors. 4.2% of Penumbra shares are owned by company insiders. Comparatively, 18.2% of Warby Parker shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Penumbra has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Penumbra$1.19B7.92$14.01M$1.06228.77
Warby Parker$771.32M3.20-$20.39M-$0.12-196.75

Penumbra has a beta of 0.4, indicating that its stock price is 60% less volatile than the S&P 500. Comparatively, Warby Parker has a beta of 2.09, indicating that its stock price is 109% more volatile than the S&P 500.

Summary

Penumbra beats Warby Parker on 13 of the 17 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WRBY vs. The Competition

MetricWarby ParkerCONS PD IndustryStaples SectorNYSE Exchange
Market Cap$2.50B$31.58B$15.75B$20.69B
Dividend YieldN/A2.70%3.20%3.67%
P/E Ratio-196.7530.9118.5229.07
Price / Sales3.201.7545.8966.55
Price / Cash70.5516.1414.5022.84
Price / Book7.058.295.884.43
Net Income-$20.39M$1.19B$690.35M$994.22M
7 Day Performance-3.18%-6.39%-5.09%-3.35%
1 Month Performance7.51%-4.08%-3.51%-2.06%
1 Year Performance55.33%-2.14%0.01%10.15%

Warby Parker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WRBY
Warby Parker
2.087 of 5 stars
$23.61
-1.4%
$23.13
-2.1%
+48.9%$2.50B$771.32M-196.753,780News Coverage
Positive News
Upcoming Earnings
Analyst Forecast
Short Interest ↑
PEN
Penumbra
4.6111 of 5 stars
$229.90
-1.4%
$305.07
+32.7%
+41.6%$9.03B$1.19B216.894,500Trending News
Earnings Report
Analyst Forecast
Analyst Revision
STVN
Stevanato Group
1.9357 of 5 stars
€25.77
-2.8%
N/A+28.7%€7.80B€1.19B50.535,521Upcoming Earnings
GKOS
Glaukos
3.9692 of 5 stars
$94.80
+0.5%
$134.67
+42.1%
-26.6%$5.39B$383.48M-40.00780Trending News
Earnings Report
Analyst Forecast
BLCO
Bausch + Lomb
2.7085 of 5 stars
$14.47
+1.0%
$15.45
+6.8%
-19.8%$5.07B$4.79B-14.0513,500News Coverage
Earnings Report
Analyst Forecast
SLNO
Soleno Therapeutics
4.2762 of 5 stars
$85.25
-1.4%
$108.70
+27.5%
+74.8%$4.36BN/A-18.4530Positive News
Upcoming Earnings
IRTC
iRhythm Technologies
1.7857 of 5 stars
$137.11
+2.2%
$137.30
+0.1%
+95.9%$4.28B$591.84M-43.672,000Trending News
Earnings Report
Analyst Forecast
Gap Up
INSP
Inspire Medical Systems
4.7194 of 5 stars
$130.72
+1.4%
$208.55
+59.5%
-13.1%$3.80B$802.80M60.241,246Positive News
Upcoming Earnings
TMDX
TransMedics Group
2.4919 of 5 stars
$105.24
-2.7%
$129.88
+23.4%
-20.4%$3.66B$441.54M77.38210Trending News
Earnings Report
Analyst Forecast
NVST
Envista
3.5735 of 5 stars
$20.73
-0.3%
$20.23
-2.4%
+22.7%$3.53B$2.51B-3.1712,300Trending News
Earnings Report
Analyst Forecast
PRCT
PROCEPT BioRobotics
2.6459 of 5 stars
$54.08
-2.9%
$84.13
+55.6%
-19.4%$3.08B$224.50M-31.81430Upcoming Earnings

Related Companies and Tools


This page (NYSE:WRBY) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners